Oyagüez I, Gómez-Peralta F, Artola S, Carrasco FJ, Carretero J, García-Saoidan J, Gómez-Huelgas R, Merino-Torres JF, Perez A
Cost analysis of FreeStyle Libre 2 system in Type 2 Diabetes Mellitus population
Diabetes Therapy. https://doi.org/10.1007/s13300-021-01064-4
Ibáñez R, Mareque M, Granados R, Andía D, García-Rojo M, Quílez JC, Oyagüez I
Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain
BMC Womens Health. 2021;21(1):178
Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyagüez I, Brockbank J, Iglesias T, Llinares J, Sierra J
Cost-effectiveness analysis of gemtuzumab ozogamicin for first-line treatment of patients with CD-33 positive acute myeloid leukaemia in Spain
ClinicoEconomics and Outcomes Research 2021; 13:263-277
de Andrés-Nogales F, Cruz E, Calleja MA, Delgado O, Gorgas Torner MQ, Espín J, Mestre-Ferrándiz J, Palau F, Ancochea A, Arce R, Domínguez-Hernández R, Casado MA and on behalf of the FinMHU-MCDA Group
A Multi-Stakeholder Multicriteria Decision Analysis for the Reimbursement of Orphan Drugs (FinMHU-MCDA study)
Orphanet J Rare Dis. 2021 Apr 26;16(1):186
Taxonera C, de Andrés-Nogales F, García-López S, Sánchez-Guerrero A, Menchén B, Peral C, Cábez A, Gómez S, López-Ibáñez de Aldecoa A, Casado MA, Menchén L
Cost-Effectiveness Analysis of Using Innovative Therapies for the Management of Moderate-To-Severe Ulcerative Colitis in Spain
Expert Rev Pharmacoecon Outcomes Res. 2021. Doi: .1080/14737167.2021.1880324
Cassinello J, Dominguez-Lubillo T, Gómez-Barrera M, Hernando T, Parra R, Asensio I, Casado MA, Moreno P